SCM

Soleus Capital Management Portfolio holdings

AUM $1.45B
This Quarter Return
+25.2%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
AUM
$697M
AUM Growth
+$697M
Cap. Flow
-$125M
Cap. Flow %
-17.88%
Top 10 Hldgs %
45.64%
Holding
97
New
21
Increased
21
Reduced
26
Closed
24

Sector Composition

1 Healthcare 97.09%
2 Consumer Staples 1.8%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RCKT icon
76
Rocket Pharmaceuticals
RCKT
$358M
-25,300
Closed -$404K
VRDN icon
77
Viridian Therapeutics
VRDN
$1.59B
-19,518
Closed -$400K
VSTM icon
78
Verastem
VSTM
$585M
-137,042
Closed -$1.4M
NVRO
79
DELISTED
NEVRO CORP.
NVRO
-72,000
Closed -$3.36M
EIGR
80
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-7,300
Closed -$1.65M
ADVM icon
81
Adverum Biotechnologies
ADVM
$68.2M
-558,779
Closed -$5.31M
ALNY icon
82
Alnylam Pharmaceuticals
ALNY
$58.6B
-27,000
Closed -$5.4M
APLS icon
83
Apellis Pharmaceuticals
APLS
$3.51B
-13,400
Closed -$915K
BIIB icon
84
Biogen
BIIB
$20.5B
-23,200
Closed -$6.19M
CSTL icon
85
Castle Biosciences
CSTL
$673M
-297,840
Closed -$7.77M
FATE icon
86
Fate Therapeutics
FATE
$119M
-67,300
Closed -$1.51M
IMUX icon
87
Immunic
IMUX
$79.4M
-240,000
Closed -$758K
INMD icon
88
InMode
INMD
$917M
-67,449
Closed -$1.96M
IOBT icon
89
IO Biotech
IOBT
$110M
-288,119
Closed -$781K
IOVA icon
90
Iovance Biotherapeutics
IOVA
$800M
-1,025,200
Closed -$9.82M
MIRM icon
91
Mirum Pharmaceuticals
MIRM
$3.75B
-135,618
Closed -$2.85M
NRIX icon
92
Nurix Therapeutics
NRIX
$723M
-504,144
Closed -$6.57M
NTRA icon
93
Natera
NTRA
$23B
-275,673
Closed -$12.1M
NVO icon
94
Novo Nordisk
NVO
$252B
-28,200
Closed -$1.41M
DALS
95
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
-50,000
Closed -$487K
APEN
96
DELISTED
Apollo Endosurgery, Inc.
APEN
-1,137,105
Closed -$6.27M